HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 37, 35850-35855, September 12, 2003

This Article Abstract Full Text (PDF) All Versions of this Article: 278/37/35850    most recent M303425200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Llorente, A. Articles by Sandvig, K. Search for Related Content PubMed PubMed Citation Articles by Llorente, A. Articles by Sandvig, K. Social Bookmarking                      What's this?

Induction of Direct Endosome to Endoplasmic Reticulum Transport in Chinese Hamster Ovary (CHO) Cells (LdlF) with a Temperature-sensitive Defect in -Coatomer Protein (-COP)^*

Alicia Llorente , Silje U. Lauvrak , Bo van Deurs  and Kirsten Sandvig  ¶

From the Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway and the Structural Cell Biology Unit, Department of Medical Anatomy, The Panum Institute, DK-2200 Copenhagen N, Denmark

Received for publication, April 2, 2003 , and in revised form, June 30, 2003.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
In the present study we demonstrate that ricin, apparently without passing through the Golgi apparatus, reaches the endoplasmic reticulum (ER) and intoxicates cells in which the Golgi apparatus has been vesiculated by depletion of -COP, a subunit of COPI. LdlF cells contain a temperature-sensitive mutation in -COP. At the nonpermissive temperature -COP is degraded, and the Golgi apparatus undergoes a morphological change. To study ricin transport in these cells we used ricin sulf-2, a modified ricin molecule containing glycosylation and sulfation sites. Measurements of the incorporation of radioactive mannose into ricin sulf-2 showed that ricin reached the ER in cells depleted of -COP. Importantly, by investigating the glycosylation of ricin sulf-2 that was modified with radioactive sulfate in the trans-Golgi network, it was demonstrated that transport of ricin to the ER via the Golgi apparatus was severely inhibited. Moreover, we found that ricin was able to intoxicate ldlF cells depleted of -COP in the presence of brefeldin A. In contrast, control cells were completely protected against ricin by brefeldin A. In conclusion, our results suggest that in ldlF cells depleted of -COP ricin might be transported to the ER by an induced brefeldin A-resistant pathway that circumvents the Golgi apparatus.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
It is well established that a number of protein toxins reach the cytosol and exert their toxic effects after retrograde transport from the cell surface to the Golgi apparatus and to the endoplasmic reticulum (ER)¹ (for review see Ref. 1). The plant toxin ricin consists of two polypeptide chains (A and B) linked by a disulfide bond. Ricin binds to both glycolipids and glycoproteins with terminal galactose via its B-chain and can therefore serve as a membrane marker. From the endosomal compartment ricin is partly recycled to the cell surface, partly degraded in the lysosomes, and partly transported to the Golgi apparatus and the ER (1, 2). From the ER ricin is translocated to the cytosol where the A-chain inhibits protein synthesis. Coat proteins regulate membrane traffic and may be involved in one or several steps in ricin trafficking (3, 4). In this study we have investigated the role of an intact COPI coat for ricin trafficking. The COPI coat has been reported to be involved in transport between the Golgi cisternae, the Golgi apparatus and the ER, early and late endosomes, and the endosomal compartment and the Golgi apparatus (5–11). One way to interfere with coat assembly is to use the fungal metabolite brefeldin A (BFA), which inhibits the binding of COPI to membranes (12). As a consequence of this inhibition, the Golgi stacks disassemble and redistribute into the ER (13, 14). Endocytosis of ricin and its transport to the trans-Golgi network (TGN) is unchanged in the presence of BFA (15). However, BFA protects against ricin in cells with a BFA-sensitive Golgi apparatus (15, 16). The protective effect of BFA against ricin toxicity might be due to a requirement of COPI for the transport of ricin from the TGN to the ER, or it might be caused by the redistribution of the Golgi stacks into the ER. Another way to investigate the involvement of COPI in trafficking is to use the CHO-derived mutant cell line ldlF (17). This cell line contains a temperature-sensitive mutation in the COPI subunit -COP that causes its degradation at the nonpermissive temperature (18). Following incubation at the nonpermissive temperature, the ER to Golgi transport (17) and the early to late endosome transport (9, 10) are impaired. In addition, the Golgi apparatus is disrupted and the structure of the early endosomes is changed (9, 19). It was recently reported that ricin can intoxicate ldlF cells depleted of -COP, and it was suggested that intoxication takes place after retrograde transport of ricin from the Golgi apparatus to the ER and to the cytosol (20). To investigate the various steps of ricin transport in cells depleted of -COP, we have measured the incorporation of radioactive sulfate and radioactive mannose into a modified ricin molecule containing sulfation and glycosylation sites in ldlF cells lacking -COP. Interestingly, our results suggest that ricin is transported to the ER from the endosomal compartment by a novel mechanism bypassing the Golgi apparatus.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Materials—Ricin, ricin B-chain, bafilomycin A₁, Hepes, fetal bovine serum, nocodazole, methyl--cyclodextrin, cytochalasin D, and lactose were obtained from Sigma. Na₂ ³⁵SO₄ was obtained from Amersham Biosciences. Na¹²⁵I was obtained from DuPont. [³H]Mannose and [³H]leucine were from PerkinElmer Life Sciences. Brefeldin A was obtained from Epicenter Technologies (Madison, WI). Ricin was labeled by the iodogen method (21) to a specific activity of 30,000–40,000 cpm/ng.

Cells and Cell Culture—Wild type CHO and the temperature-sensitive mutant ldlF cells were kindly provided by Dr. Monty Krieger (Massachusetts Institute of Technology, Cambridge, MA) and cultured as previously described (19). The cells were maintained in Ham's F-12 medium (Bio-Whittaker, Verviers, Belgium) supplemented with 5% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine at 34 °C (permissive temperature), and shifted or not to 40 °C (nonpermissive temperature) overnight before running the experiments.

Measurements of Endocytosis and Degradation—Endocytosed ricin was measured as the amount of ¹²⁵I-labeled toxin that could not be removed by incubating the cells with a 0.1 M lactose solution for 5 min at 37 °C. The degradation of ¹²⁵I-labeled ricin was measured as the amount of radioactivity that could not be precipitated by trichloroacetic acid after 4 h (22).

Measurements of Protein Synthesis—The cells were incubated in medium without leucine in the presence of 2 µCi/ml [³H]leucine for 20 min at 37 °C. The medium was then removed and the cells were washed twice with 5% (w/v) trichloroacetic acid for 10 min. Finally, the cells were solubilized in KOH (0.1 M) and the acid-precipitable radioactivity was measured. The results are expressed in percent of [³H]leucine incorporated in cells incubated without toxin. Deviations between duplicates did not vary by more than 10%.

Sulfation and Mannosylation of Ricin Sulf-2—Ricin A-chain sulf-2 containing a sulfation site and three partially overlapping N-glycosylation sites in the carboxyl terminus was produced, purified, and reconstituted with ricin B-chain to form ricin sulf-2 as previously described (23). The cells were incubated with 600 µCi/ml Na³⁵SO₄ in DMEM without sulfate or with 70 µCi/ml [³H]mannose in DMEM without glucose (Invitrogen). 30 min later ricin sulf-2 (500 ng/ml) was added, and the incubation was continued for6hat37 °Corfor4hand then 4 h in the absence of ricin and radioactive sulfate. The cells were then washed with a 0.1 M lactose solution at 37 °C and once with cold phosphate-buffered saline, lyzed (lysis buffer: 0.1 M NaCl, 10 mM Na₂HPO₄, 1 mM EDTA, 1% Triton X-100, pH 7.4) in the presence of a protease inhibitor mixture (Roche Diagnostics), and centrifuged to remove the nuclei for 10 min at 5000 rpm in an Eppendorf centrifuge (model 5415). The supernatant was immunoprecipitated with rabbit anti-ricin antibodies immobilized on protein A-Sepharose CL-4B (Amersham Biosciences). Finally, the beads were washed with cold phosphate-buffered saline containing 0.35% Triton X-100, and the adsorbed material was analyzed by SDS-PAGE (12%) under reducing conditions. The radioactivity in the cell lysates was measured to detect differences in the total amount of isotope incorporated in the different conditions.

SDS-PAGE—SDS-PAGE was done as described by Laemmli (24). The gels were fixed in 4% acetic acid and 27% methanol for 30 min and then treated with 1 M sodium-salicylate (pH 5.8) in 2% glycerol for 15 min. Dried gels were exposed to Kodak XAR-5 films (Rochester, NY) at –80 °C or to phosphor screens (Amersham Biosciences).

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Ricin Intoxicates Cells Lacking -COP by a BFA-resistant Mechanism—Intoxication with ricin normally requires ricin endocytosis and transport from the endosomes to the Golgi apparatus and then to the ER, from where the toxin is translocated to the cytosol and then inhibits protein synthesis (1, 2). In ldlF cells incubated at the nonpermissive temperature (40 °C) -COP is degraded and COPI function is impaired. It has previously been shown (9, 10) that in these cells endocytosis continues but that the transport from late endosomes to lysosomes is impaired. In agreement with these results, the endocytosis of ricin continues in ldlF cells at the nonpermissive temperature (data not shown), but ricin degradation is severely reduced (Fig. 1).

View larger version (14K): [in this window] [in a new window]   FIG. 1. Ricin degradation in CHO and ldlF cells incubated overnight at 40 °C. CHO and LdlF cells were incubated overnight at 40 °C (permissive temperature) in culture medium. The cells were washed in Ham's F-12 medium without serum and incubated with 125I-ricin for 20 min. Then, surface-bound ricin was removed with a 0.1 M lactose solution, and medium containing 1 mM lactose was added to avoid binding of recycled ricin to the cell membrane. 4 h later the amount of radioactivity in the medium that could not be precipitated by trichloroacetic acid was measured. Bars represent the deviation between parallels of a representative experiment.

As a consequence of impaired COPI function, the Golgi apparatus is partially redistributed into an ER-like structure and partially into patch-like structures (19, 25). Importantly, as in many other cell lines (13, 14), BFA causes the redistribution of the Golgi into the ER in ldlF cells depleted of -COP (25). To investigate whether ricin was able to reach the cytosol and intoxicate ldlF cells at the nonpermissive temperature both in the absence and in the presence of BFA, we measured the ability of ricin to inhibit protein synthesis both in the absence and in the presence of this drug. Interestingly, as shown in Fig. 2A, ricin was able to intoxicate ldlF cells grown at the nonpermissive temperature (40 °C) in the presence of BFA, although at a lower extent compared with untreated cells. However, BFA severely inhibited the intoxication of ricin in CHO cells grown at 40 °C (Fig. 2B). Because the delivery of ricin to lysosomes is strongly inhibited in ldlF cells grown at the nonpermissive temperature (Fig. 1), a toxicity experiment was also performed in the presence of bafilomycin A₁, which will inhibit transport to lysosomes and degradation. Importantly, also in the presence of bafilomycin A₁, ldlF cells and CHO cells grown at the nonpermissive temperature respond differently to BFA (Fig. 2, C and D), thus suggesting that the fact that ricin can intoxicate ldlF cells grown at the nonpermissive temperature in the presence of BFA is not due to the inhibition of ricin degradation and the higher intracellular amount of ricin that these cells may have. It should also be noticed that a similar concentration of ricin was required to intoxicate ldlF cells and CHO cells in the presence of bafilomycin A₁ (Fig. 2, C versus D, without BFA), thus suggesting that the differences in ricin toxicity between ldlF cells and CHO cells (Fig. 2, A versus B, without BFA) may be due to the larger amount of ricin that is degraded in CHO cells. Finally, in some experiments the effect of BFA on ricin toxicity in ldlF cells grown overnight at the permissive (34 °C) or at the nonpermissive temperature (40 °C) was compared. Because many transport steps are temperature-sensitive these experiments were performed at 37 °C after testing that COPI remains unfunctional at the end of the experiment in ldlF cells incubated overnight at 40 °C (data not shown). As shown in Fig. 2, E and F, in the presence of BFA ricin intoxicates ldlF cells lacking -COP (preincubated at 40 °C), but not control ldlF cells (preincubated at 34 °C). In conclusion, these experiments suggest that in ldlF cells lacking -COP ricin may reach the cytosol bypassing the Golgi apparatus, and that neither incubation of cells (CHO) at 40 °C nor inhibition of lysosomal degradation are sufficient to induce a BFA-resistant intoxication pathway.

View larger version (21K): [in this window] [in a new window]   FIG. 2. Effect of BFA on the ability of ricin to inhibit protein synthesis in CHO and ldlF cells. LdlF (A) and CHO (B) cells were incubated overnight at 40 °C (nonpermissive temperature) in culture medium. The cells were then washed in Ham's F-12 medium without serum and incubated for 30 min at 40 °C in the absence (•) or in the presence () of BFA (2 µg/ml). Increasing concentrations of toxin were then added, and 6 h later protein synthesis was measured as described under "Experimental Procedures." C and D, same as A and B, but the cells were incubated for 30 min with bafilomycin A1 (baf.) (0.25 µM) before addition of BFA (2 µg/ml). Ricin was then added, and the cells were incubated with toxin for 4 h. E and F, same as A, but ldlF cells were preincubated overnight at 40 °C or 34 °C, and the cells were incubated with ricin for 4 h at 37 °C. The figure shows the average between duplicates of representative experiments.

Ricin Is Transported to the ER in LdlF Cells Lacking -COP Bypassing the Golgi Apparatus—The previous toxicity experiments suggest that ricin enters the cytosol of ldlF cells lacking -COP by a different mechanism than in other cells. To investigate the routing of ricin in ldlF cells lacking -COP we used ricin sulf-2, a modified ricin molecule containing a tyrosine sulfation site and three partially overlapping N-glycosylation sites at the carboxyl terminus of the A-chain (23). Ricin sulf-2 has previously been used to monitor the transport of the toxin to the TGN (site of sulfation (26)) and to the ER (site of glycosylation). To investigate whether ricin reached the ER in ldlF cells depleted of -COP, we measured the glycosylation of ricin sulf-2 by directly quantifying the incorporation of [³H]mannose into the toxin molecule. It has previously been shown (17) that several ER-associated reactions, including addition of high mannose N-linked oligosaccharides, occur normally in cells lacking -COP. Interestingly, ricin sulf-2 labeled with [³H]mannose was detected in control ldlF cells (preincubated at 34 °C) and in ldlF cells lacking -COP (preincubated at 40 °C) (Fig. 3A), although the amount of labeled ricin in ldlF cells lacking -COP was reduced by 30% (Fig. 3B). This experiment shows that ricin can reach the ER in ldlF cells lacking -COP. Furthermore, to test the hypothesis that ricin is transported to the ER and to the cytosol bypassing the Golgi apparatus, ldlF cells were incubated with ricin sulf-2 in the presence of radioactive sulfate. When ricin sulf-2 was added to control ldlF cells (preincubated at 34 °C) in the presence of radioactive sulfate and immunoprecipitated from cell lysates, two main labeled bands were visible (Fig. 3C, left lane, the two upper bands). It has previously been shown (23) in other cells lines that the band with the lowest molecular weight of these two bands represents ricin that has been sulfated in the TGN, and the band with the highest molecular weight of these two represents ricin that has been both sulfated in the TGN and glycosylated in the ER. This seems also to be the case in control ldlF cells because only the band with the highest molecular weight was observed when ricin-sulf 2 and radioactive sulfate was removed from the medium after 4 h, and the incubation was continued for 4 h more to allow sulfated ricin to be transported to the ER and be glycosylated (data not shown). In some experiments a third labeled band with a lower molecular weight was observed (Fig. 3C, lowest band), this band probably being a degradation product. Interestingly, we found that ricin sulf-2 also was sulfated in ldlF cells preincubated at the nonpermissive temperature (40 °C) (Fig. 3C) although to a lower extent (5-fold reduction) (in Fig. 3C, lane 34 °C and lane 40 °C show different film exposures). The molecular weight of the band corresponding to sulfated ricin was slightly different in cells preincubated at 34 °C and 40 °C (compare middle band in Fig. 3C). Interestingly, whereas in control cells (ldlF cells preincubated at the permissive temperature) 45% of the total amount of sulfated ricin was transported to the ER (Fig. 3D), only minimal amounts of ricin sulf-2, which was both sulfated and glycosylated, were observed in ldlF cells preincubated at the nonpermissive temperature (Fig. 3C, 40 °C), thus suggesting that the transport of ricin from the Golgi apparatus to the ER is severely inhibited in ldlF cells lacking -COP and supporting the idea that ricin is able to reach the ER and intoxicate these cells bypassing the Golgi apparatus.

View larger version (32K): [in this window] [in a new window]   FIG. 3. Sulfation and glycosylation of ricin sulf-2 in ldlF cells incubated overnight at 34 °C or at 40 °C. LdlF cells were incubated overnight at 34 °C (permissive temperature) or at 40 °C (nonpermissive temperature) in culture medium. The cells were then incubated at 37 °C with 70 µCi/ml [3H]mannose in DMEM without glucose (A and B) or with 600 µCi/ml Na35SO4 in DMEM without sulfate (C and D). 30 min later ricin sulf-2 was added and the cells were incubated for 6 h at 37 °C. Labeled toxin was detected as described under "Experimental Procedures." The bands at 34 °C and 40 °C in C result from different film exposures. Panels A and C show representative gels. Panels B and D show quantifications from 3–4 experiments as shown in panel A and C, respectively. The asterisk in panel D indicates that the signal was too weak to be quantified.

Characterization of Ricin Trafficking in -COP-deficient Cells—It has previously been shown that ricin is internalized but does not intoxicate cells at 17 °C. To investigate whether this was the case also in ldlF cells lacking -COP, a toxicity experiment was performed at 17 °C with ldlF cells preincubated at the permissive or at the nonpermissive temperature. As shown in Fig. 4A, neither control ldlF cells grown at the permissive temperature (34 °C) nor ldlF cells grown at the nonpermissive temperature (40 °C) were intoxicated with ricin at 17 °C, thus indicating that the transport of ricin to the ER in cells lacking -COP also requires a temperature-sensitive step. In addition, COPI or another BFA-sensitive coat may be involved in the induction of the BFA-insensitive pathway in ldlF cells depleted of -COP because when BFA was present during the overnight incubation of ldlF cells at 40 °C as well as during the toxicity experiment, ricin was no longer able to intoxicate ldlF cells lacking -COP (Fig. 4B).

View larger version (15K): [in this window] [in a new window]   FIG. 4. Ricin does not intoxicate ldlF cells grown overnight at 40 °C with BFA or ldlF cells lacking -COP at 17 °C. A, ldlF cells were incubated overnight at 34 °C (permissive temperature) () or at 40 °C (nonpermissive temperature) (•) in culture medium. The cells were then washed in Ham's F-12 medium without serum and incubated at 17 °C with increasing concentrations of toxin. 4 h later protein synthesis was measured as described under "Experimental Procedures." B, ldlF cells were incubated overnight at 40 °C (nonpermissive temperature) with () or without (•) BFA (2 µg/ml), and then increasing concentrations of toxin were added at 40 °C. 4 h later protein synthesis was measured as described under "Experimental Procedures." The figures show the average between duplicates of representative experiments.

Direct trafficking from a specialized endosomal compartment (caveosome) to the ER was recently demonstrated for simian virus 40 (27). This transport step was reported to be dependent on microtubules, and we therefore tested whether ricin intoxication in ldlF cells lacking -COP could be inhibited by nocodazole. As shown in Fig. 5, neither disruption of microtubules with nocodazole (16 µM), nor of the actin cytoskeleton with cytochalasin D (1 µM), affected the toxicity of ricin in ldlF cells depleted of -COP. Because it has previously been found that cholesterol is important for ricin trafficking (2, 28), we also investigated whether depletion of cholesterol would affect ricin toxicity in ldlF cells. As shown in Fig. 5C, reduction of membrane cholesterol by addition of methyl--cyclodextrin (2.5 mM) slightly increased the toxicity of ricin in control ldlF cells (34 °C), but decreased the toxicity of the toxin in ldlF cells lacking -COP (40 °C).

View larger version (19K): [in this window] [in a new window]   FIG. 5. Effect of nocodazole, cytochalasin D, and methyl--cyclodextrin on the ability of ricin to inhibit protein synthesis in ldlF cells incubated overnight at 34 °C or at 40 °C. LdlF cells were incubated overnight at 34 °C (permissive temperature) (, ) or at 40 °C (nonpermissive temperature) (•, ) in culture medium. The cells were then washed in Ham's F-12 medium without serum and incubated for 30 min at 37 °C with (, ) or without ( •) nocodazole (noc.) (16.5 µM) (A), cytochalasin D (cyt. D) (1 µM) (B), or methyl--cyclodextrin (mCD) (2.5 mM) (C). Increasing concentrations of toxin were then added and 4 h later protein synthesis was measured as described under "Experimental Procedures." The figure shows the average between duplicates of a representative experiment.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
The most important finding of this study is that the toxin ricin seems to be transported to the ER and to the cytosol bypassing the Golgi apparatus in ldlF cells lacking -COP (Fig. 6). In ldlF cells lacking -COP after incubation at the nonpermissive temperature (40 °C), the function of COPI is impaired and the Golgi apparatus is disrupted (19). Nevertheless, ricin is transported to the ER and intoxicates these cells. Under normal conditions ricin intoxicates cells after being transported from the endosomal compartment to the Golgi apparatus, and then to the ER. However, our experiments indicate that ricin can be transported to the ER by an alternative mechanism in ldlF cells lacking -COP. As shown, the transport of ricin from the Golgi apparatus to the ER (revealed by studies of sulfate-labeled ricin) is severely inhibited in ldlF cells lacking -COP. Secondly, BFA only inhibits the toxicity of ricin to some extent in ldlF cells lacking -COP (incubated at the nonpermissive temperature, 40 °C), but completely in control ldlF cells (incubated at the permissive temperature, 34 °C). These results cannot be explained by a lack of effect of BFA on the Golgi structure because it has previously been shown that BFA causes the redistribution of the disturbed Golgi apparatus into the ER in ldlF cell depleted of -COP (25). Importantly, the difference in toxicity in the presence of BFA in ldlF cells and CHO cells at the nonpermissive temperature is not caused by the higher intracellular amount of ricin in the ldlF cells because a similar difference was observed when the experiment was performed in the presence of bafilomycin A₁.

View larger version (22K): [in this window] [in a new window]   FIG. 6. Transport of ricin to the ER in ldlF cells incubated overnight at 34 °C or at 40 °C. A, transport of ricin to the ER in control ldlF cells. Under normal conditions ricin intoxicates cells after being transported from the endosomal compartment to the Golgi apparatus, and then to the ER. Sulfation experiments show that ricin sulf-2 that has been sulfated in the TGN is glycosylated in the ER. The transport to the cytosol is BFA-sensitive. B, transport of ricin to the ER in ldlF cells lacking -COP. Ricin seems to be transported to the ER by an alternative mechanism in ldlF cells lacking -COP. Sulfation experiments show that ricin sulf-2 that has been sulfated in the TGN is not glycosylated in the ER. However, mannosylation experiments show that ricin incorporates radioactive mannose in the ER. The transport to the cytosol is BFA-resistant.

It is not clear at the moment why the toxicity of ricin is inhibited to some extent by BFA in ldlF cells depleted of -COP. The possibility exists that there is more than one transport route from the endosomal compartment to the ER under these conditions and that only one is sensitive to BFA, or it could be that there is one pathway that is only partially sensitive to inhibition by BFA. However, it is unlikely that the inhibition of toxicity by BFA reflects an effect of the drug on the transport of ricin passing through the vesiculated Golgi, because there is only a very small fraction of sulfated ricin that is transported from the TGN (sulfation site) to the ER and glycosylated.

It was recently reported that ricin-intoxication of ldlF cells transfected with cDNA encoding wild type -COP at 40 °C is only partially sensitive to BFA (20). It is not clear why BFA did not completely inhibit the toxicity of ricin in ldlF cells transfected with wild-type -COP at 40 °C, but it is possible that there is still an effect of the temperature-sensitive form of -COP in these cells. A changed conformation or the degradation of the temperature-sensitive protein might still affect the cells.

It has been shown that the simian virus 40 is directly transported to the ER from non-classical endosomes termed caveosomes, and that this process requires intact microtubuli (27). Unlike the simian virus 40, transport of ricin to the cytosol does not require microtubuli, suggesting that caveosomes are not involved in ricin transport to the ER in ldlF cells lacking -COP.

Recent data indicate that ricin is transported to the Golgi apparatus from the early/recycling compartment (29). In agreement with this idea we show here that ricin can intoxicate ldlF cells depleted of -COP, where the transport from early to late endosomes is inhibited (10). Altogether our experiments suggest that ricin intoxicates ldlF cells lacking -COP by using an alternative pathway that bypasses the Golgi apparatus.

	FOOTNOTES

 
^* This work was supported by The Norwegian and The Danish Cancer Societies, The Danish Medical Research Council, The Norwegian Research Council for Science and Humanities, The Novo Nordisk Foundation, The Jahre Foundation, and The Jeanette and Søren Bothners legacy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed. Tel.: 47-22934294; Fax: 47-22508692; E-mail: ksandvig{at}radium.uio.no.

¹ The abbreviations used are: ER, endoplasmic reticulum; TGN, trans-Golgi network; BFA, brefeldin A; DMEM, Dulbecco's modified Eagle's medium; CHO, Chinese hamster ovary; -COP, -coatomer protein; COPI, coatomer protein complex I.

	ACKNOWLEDGMENTS

 
We are grateful to Inger Johanne Eide, Anne-Grethe Myrann, and Britt Solvår Morken for expert technical assistance.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Sandvig, K., and van Deurs, B. (2002) Annu. Rev. Cell Dev. Biol. 18, 1–24[CrossRef][Medline] [Order article via Infotrieve]
2. Sandvig, K., Grimmer, S., Lauvrak, S. U., Torgersen, M. L., Skretting, G., van Deurs, B., and Iversen, T. G. (2002) Histochem. Cell Biol. 117, 131–141[CrossRef][Medline] [Order article via Infotrieve]
3. Kirchhausen, T. (2000) Nat. Rev. Mol. Cell. Biol. 1, 187–198[CrossRef][Medline] [Order article via Infotrieve]
4. Scales, S. J., Gomez, M., and Kreis, T. E. (2000) Int. Rev. Cytol. 195, 67–144[Medline] [Order article via Infotrieve]
5. Lowe, M., and Kreis, T. E. (1998) Biochim. Biophys. Acta 1404, 53–66[Medline] [Order article via Infotrieve]
6. Barlowe, C. (2000) Traffic 1, 371–377[CrossRef][Medline] [Order article via Infotrieve]
7. Richards, A. A., Stang, E., Pepperkok, R., and Parton, R. G. (2002) Mol. Biol. Cell 13, 1750–1764[Abstract/Free Full Text]
8. Mallard, F., Antony, C., Tenza, D., Salamero, J., Goud, B., and Johannes, L. (1998) J. Cell Biol. 143, 973–990[Abstract/Free Full Text]
9. Gu, F., Aniento, F., Parton, R. G., and Gruenberg, J. (1997) J. Cell Biol. 139, 1183–1195[Abstract/Free Full Text]
10. Daro, E., Sheff, D., Gomez, M., Kreis, T., and Mellman, I. (1997) J. Cell Biol. 139, 1747–1759[Abstract/Free Full Text]
11. Aniento, F., Gu, F., Parton, R. G., and Gruenberg, J. (1996) J. Cell Biol. 133, 29–41[Abstract/Free Full Text]
12. Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992) Nature 360, 350–352[CrossRef][Medline] [Order article via Infotrieve]
13. Doms, R. W., Russ, G., and Yewdell, J. W. (1989) J. Cell Biol. 109, 61–72[Abstract/Free Full Text]
14. Lippincott-Schwartz, J., Donaldson, J. G., Schweizer, A., Berger, E. G., Hauri, H. P., Yuan, L. C., and Klausner, R. D. (1990) Cell 60, 821–836[CrossRef][Medline] [Order article via Infotrieve]
15. Sandvig, K., Prydz, K., Hansen, S. H., and van Deurs, B. (1991) J. Cell Biol. 115, 971–981[Abstract/Free Full Text]
16. Yoshida, T., Chen, C. C., Zhang, M. S., and Wu, H. C. (1991) Exp. Cell Res. 192, 389–395[CrossRef][Medline] [Order article via Infotrieve]
17. Hobbie, L., Fisher, A. S., Lee, S., Flint, A., and Krieger, M. (1994) J. Biol. Chem. 269, 20958–20970[Abstract/Free Full Text]
18. Guo, Q., Penman, M., Trigatti, B. L., and Krieger, M. (1996) J. Biol. Chem. 271, 11191–11196[Abstract/Free Full Text]
19. Guo, Q., Vasile, E., and Krieger, M. (1994) J. Cell Biol. 125, 1213–1224[Abstract/Free Full Text]
20. Chen, A., Hu, T., Mikoryak, C., and Draper, R. K. (2002) Biochim. Biophys. Acta 1589, 124–139[Medline] [Order article via Infotrieve]
21. Fraker, P. J., and Speck, J. C., Jr. (1978) Biochem. Biophys. Res. Commun. 80, 849–857[CrossRef][Medline] [Order article via Infotrieve]
22. Sandvig, K., and Olsnes, S. (1979) Exp. Cell Res. 121, 15–25[CrossRef][Medline] [Order article via Infotrieve]
23. Rapak, A., Falnes, P. Ø., and Olsnes, S. (1997) Proc. Natl. Acad. Sci. 94, 3783–3788[Abstract/Free Full Text]
24. Laemmli, U. K. (1970) Nature 227, 680–685[CrossRef][Medline] [Order article via Infotrieve]
25. Gomez, M., Scales, S. J., Kreis, T. E., and Perez, F. (2000) J. Biol. Chem. 275, 29162–29169[Abstract/Free Full Text]
26. Baeuerle, P. A., and Huttner, W. B. (1987) J. Cell Biol. 105, 2655–2664[Abstract/Free Full Text]
27. Pelkmans, L., Kartenbeck, J., and Helenius, A. (2001) Nat. Cell Biol. 3, 473–483[CrossRef][Medline] [Order article via Infotrieve]
28. Grimmer, S., Iversen, T. G., van Deurs, B., and Sandvig, K. (2000) Mol. Biol. Cell 11, 4205–4216[Abstract/Free Full Text]
29. Iversen, T. G., Skretting, G., Llorente, A., Nicoziani, P., van Deurs, B., and Sandvig, K. (2001) Mol. Biol. Cell 12, 2099–2107[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Walchli, S. S. Skanland, T. F. Gregers, S. U. Lauvrak, M. L. Torgersen, M. Ying, S. Kuroda, A. Maturana, and K. Sandvig The Mitogen-activated Protein Kinase p38 Links Shiga Toxin-dependent Signaling and Trafficking Mol. Biol. Cell, January 1, 2008; 19(1): 95 - 104. [Abstract] [Full Text] [PDF]

				J. B. Saenz, T. A. Doggett, and D. B. Haslam Identification and Characterization of Small Molecules That Inhibit Intracellular Toxin Transport Infect. Immun., September 1, 2007; 75(9): 4552 - 4561. [Abstract] [Full Text] [PDF]

				P. J. Tam and C. A. Lingwood Membrane cytosolic translocation of verotoxin A1 subunit in target cells Microbiology, August 1, 2007; 153(8): 2700 - 2710. [Abstract] [Full Text] [PDF]

				J. F. Roeth and K. L. Collins Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways Microbiol. Mol. Biol. Rev., June 1, 2006; 70(2): 548 - 563. [Abstract] [Full Text] [PDF]

				J. Young, T. Stauber, E. del Nery, I. Vernos, R. Pepperkok, and T. Nilsson Regulation of Microtubule-dependent Recycling at the Trans-Golgi Network by Rab6A and Rab6A' Mol. Biol. Cell, January 1, 2005; 16(1): 162 - 177. [Abstract] [Full Text] [PDF]

				A. A. Khine, P. Tam, A. Nutikka, and C. A. Lingwood Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity Glycobiology, August 1, 2004; 14(8): 701 - 712. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 278/37/35850    most recent M303425200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Llorente, A. Articles by Sandvig, K. Search for Related Content PubMed PubMed Citation Articles by Llorente, A. Articles by Sandvig, K. Social Bookmarking                      What's this?